Skip to main content

Table 1 AML target molecules

From: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients

Target antigens

Type of molecule

Role

On normal cells

On HSCs

On LSCs

On AML blasts

References

CD7

Ig superfamily/ Glycoprotein

B and T cell lymphoid development, transmembrane protein

T, NK cells, and myeloid progenitors

No

Yes

Yes

[85]

CD33

The protein of the SIGLEC family

Transmembrane receptor

Progenitor, myeloid, and kupffer cells

Yes

Yes

Yes

[86, 87]

CD38

Glycoprotein

Cyclic ADP ribose hydroxylase, a transmembrane protein

B, T, NK cells

No

Yes

Yes

[88, 89]

CD44v6

Glycoprotein

Transmembrane protein

Keratinocytes

No

Yes

Yes

[90]

CD70

Glycoprotein from the TNF family

Transmembrane protein

T and B cell

No

Yes

Yes

[91, 92]

CD123

Type I cytokine receptor of IL-3

IL-3 receptor α subunit

Myeloid progenitors, DC and, basophils

Yes

Yes

Yes

[92,93,94]

FLT3

Type III cytokine receptor

Tyrosine kinase receptor

Neurons, testis

Yes

Yes

Yes

[95, 96]

CCL1

Glycoprotein

Transmembrane receptor

Myeloid, lung, epithelial cells

No

Yes

Yes

[97, 98]

LeY

Glycosphingolipid (fucosyltransferase)

Blood group Ag

Intestinal epithelial cells

Yes

Yes

Yes

[99, 100]

FRβ

Folate-binding protein receptor

Folate delivery

Myeloid cells

No

Yes

Yes

[101]

LILRB4

Leukocyte Ig-like Receptor-B family

Inhibitory receptor role in immune tolerance

Monocytes

No

Yes

Yes

[102]

NKG2D

C-type lectin-like receptor protein

Activator receptor

NK, NKT, Tγδ, Th, and CTL

No

Yes

Yes

[103, 104]

PR1

Proteinase protein

HLA-presented antigens

Neutrophils

No

No

Yes

[105]

WT1

Zinc-finger DNA binding protein

Transcription factor

Kidney endometrium and testis cells

No

No

Yes

[106]

mLPA

Methyl-lysophosphatidic acid

CD1c-restricted T cell antigen

MO, DC, B and T cells

No

Yes

Yes

1

IDH1(R132)

Isocitrate dehydrogenase 1

Glyoxylate bypass, tricarboxylic acid cycle

Hepatocytes, cytotrophoblasts

Yes

Yes

Yes

2.3.4

IDH2(R140)

Isocitrate dehydrogenase 2

Glyoxylate bypass, tricarboxylic acid cycle

Distal tubular cells, cytotrophoblasts

Yes

Yes

Yes

5

NPM1mut

Nuclophosmin 1 mutant

Biogenesis of ribosomes, Chaperone, Host-virus interaction

Low cell and tissue type specificity

No

Yes

Yes

6,7

NOTCH2

NOTCH signaling molecule isoform 2

Developmental processes

Non-lymphoid progenitor cells, Paneth cells

Yes

Yes

Yes

8

MUC1

Glycoprotein

Protective function cell signaling

Surface of most simple epithelia and Treg cells

Yes

Yes

Yes

9, 10

CD96

Member of immunoglobulin superfamily

Adhesion of activated T and NK cells

T cells and NK cells

No

Yes

Yes

11

PRL3

Protein tyrosine phosphatase type Iva member 3

Reinforcing PI3K/Akt activation

Cardiomyocyte, neutrophil, non-classical monocyte

Yes

Yes

Yes

12, 13

IL12RB1

Interleukin 12 receptor beta 1

Cytokine signaling

T cells, Kupffer cells, B cells

Yes

Yes

Yes

11

  1. Abbreviations: AML acute myeloid leukemia; HSCs hematopoietic stem cells; LSCs Leukemic stem cells; Ig immunoglobulin; NK Natural killer cell; SIGLEC sialic acid-binding immunoglobulin-like lectin; ADP adenosine diphosphate; TNF tumor necrosis factor; FLT3 Fms-like tyrosine kinase 3; CCL1 c-type lectin-like molecule-1; LeY Lewis Y; FRβ folate receptor β; LILRB leukocyte immunoglobulin-like receptor B4; NKG2D Natural killer group 2 D; PR1 proteinase; WT1 Wilms Tumor 1; DC dendritic cell; mLPA methyl-lysophosphatidic acid; IDH1 isocitrate dehydrogenase 1; NPM1mut nuclophosmin 1 mutant; NOTCH2 NOTCH signaling molecule isoform; MUC1 mucin1; PRL3 protein tyrosine phosphatase type Iva member 3; IL12RB1 interleukin 12 receptor beta 1